Conclusion
High rates of drug-drug interactions and inappropriate prescribing were reported among ESRD patients who were on QTcP-inducing drugs in outpatient clinics in Jordan. These findings urge policymakers to implement educational programme for patients and continual training courses for pharmacists and physicians to ensure safe delivery of medications to the ESRD patients.